* Note: Prices are in Million (M) USD.
Description:
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $137 M
Debt : $12 M
EBITDA : $259 M
Since Cash is greater than Total Debt, 5 points assigned.
This criteria used industry in which company operates:
Sector: Professional, scientific, and technical services
Industry: Research and development in the physical, engineering, and life sciences (except biotechnology)
Based on industry, 5 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 39.39
Since Forward PE Ratio is greater than 35, 0 point assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Using last 7 overlapping fiscal years (max 20).Average Free Cash Flow: $122 M
Average Revenue: $317 M
Revenue Converted To Free Cash Flow (%): 38.5%
Since Free Cash Flow (FCF) to Revenue percentage is greater than 25, 5 points assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2025-03-31): $570 M
Revenue 4 Years Ago (2021-03-31): $207 M
Last 5 Years Average Revenue Growth: 35%
Since Revenue Growth is greater than 20, 5 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2025-03-31): $201 M
Share Count 5 Years Ago (2021-03-31): $178 M
Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $1.86
Trailing 12-Month Earnings Per Share (EPS): $1.59
Average Earnings Per Share (EPS): $1.73
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0%
Since Dividend Per Share is less than or equal to 0, 0 point assigned.
Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Using last 7 valid ROE years (max 20).Average ROE: 396.5%
Since Average ROE is greater than 20, 5 points assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $68
52-Week Low: $35
Threshold Price (15% Above 52-Week Low): $41
Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $12,349 M
Since Market Cap is between 10B - 100B, 2 points assigned.
% Exposure to Total Portfolio
Based on the market cap, we recommend do not exceed 3% exposure of Total Portfolio.
Value-Trade has assigned 27 points to above Doximity Inc (DOCS) stock.
Last 2 Years Avg PE 40, Fair Value PE 25, Industry Based PE 20, Growth Based PE 35, RCFC Based PE 40.8, ROE Based PE 50, Risk-Free Anchored PE (25% MoS) 17.08. Based on these 7 values, average assigned is 32.55. Value-Trades has assined P/E value 32.55. Since an average (Current Year EPS + Next Year EPS) earning per share is $1.725.
The fair value of Doximity Inc (DOCS) stock should be (32.55 x $1.725) = $56.16.
